article thumbnail

How Technology Is Improving Success Rates In Drug Clinical Trials

Electronic Health Reporter

This article is copyrighted strictly for Electronic Health Reporter. Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. Illegal copying is prohibited.

article thumbnail

The Impact of Agile In The Pharmaceutical Industry

Electronic Health Reporter

This article is copyrighted strictly for Electronic Health Reporter. As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. Without a direct relationship with […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare AI Bias: Reasons and Resolutions

Healthcare IT Today

The following is a guest article by Anand Shroff, President at Verantos.

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.

BioTech 144
article thumbnail

How Happy Cells Manufacture New Medications

Healthcare IT Today

The development and manufacturing process for these important new drugs is very different from traditional medicines. This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, Life Science Business Development Director at 908 Devices.

article thumbnail

Three Ways AI, If Trusted, Can Transform the Healthcare Landscape

Healthcare IT Today

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

The following is a guest article by Dr. Zach Landman, Co-Founder of Moonshots for Unicorns. As we saw with COVID, when treatments were needed more rapidly than the typical drug development timeline could offer, we identified existing medicines that could be repurposed (such as remdesevir and dexamethasone, among many others.)